Jump to ContentJump to Main Navigation

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred

12 Issues per year

IMPACT FACTOR increased in 2014: 3.268
Rank 106 out of 289 in category Biochemistry & Molecular Biology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 1.596
Source Normalized Impact per Paper (SNIP) 2014: 0.845
Impact per Publication (IPP) 2014: 2.992



Quantitation of Membrane Type Serine Protease 1 (MT-SP1) in Transformed and Normal Cells

A.S. Bhatt / T. Takeuchi / B. Ylstra / D. Ginzinger / D. Albertson / M.A. Shuman / C.S. Craik

Citation Information: Biological Chemistry. Volume 384, Issue 2, Pages 257–266, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2003.029, June 2005

Publication History

Published Online:


Membrane type serine protease 1 (MT-SP1) is a representative member of a large family of related enzymes known as type II transmembrane serine proteases or membrane type serine proteases. MTSP1 has been implicated in the selective proteolysis of key extracellular substrates but its physiological role is still not fully understood. MT-SP1 expression at the protein and RNA level has been previously examined by nonquantitative methods such as in situ hybridization, Northern blotting and immunohistochemistry. To establish an introductory understanding of the quantitative mRNA expression of MT-SP1 and to correlate these levels with urokinasetype plasminogen activator receptor (uPAR), a key component of extracellular proteolysis, quantitative RT-PCR was carried out. RNA expression was analyzed in 34 human cancer cell lines, 26 human tissues and 18 primary human breast cancer tissue samples. MT-SP1 mRNA is highly expressed in many breast, ovarian, prostate and colon cancer cell lines and normal human tissues of endodermal origin. At the transcript level, MT-SP1 shows a highly statistically significant correlation (Pearsons product moment correlation r = 0.784, p < 0.001) with uPAR in human breast cancer tissue. The exact role of MT-SP1 in concert with proteins such as uPAR and other members of the plasminogen activator cascade has yet to be ascertained. However, the significant correlation between MT-SP1 and uPAR transcript levels in this initial study suggests further work to establish the role of MT-SP1 as a possible prognostic, diagnostic or therapeutic target for breast cancer.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Gina L. Zoratti, Lauren M. Tanabe, Fausto A. Varela, Andrew S. Murray, Christopher Bergum, Éloïc Colombo, Julie E. Lang, Alfredo A. Molinolo, Richard Leduc, Eric Marsault, Julie Boerner, and Karin List
Nature Communications, 2015, Volume 6, Page 6776
Karin List, Roman Szabo, Alfredo Molinolo, Boye Schnack Nielsen, and Thomas H. Bugge
The American Journal of Pathology, 2006, Volume 168, Number 5, Page 1513
Alfonso Clemente, Francisco Javier Moreno, Maria del Carmen Marín-Manzano, Elisabeth Jiménez, and Claire Domoney
Molecular Nutrition & Food Research, 2010, Volume 54, Number 3, Page 396
M. Carmen Marín-Manzano, Raquel Ruiz, Elisabeth Jiménez, Luis A. Rubio, and Alfonso Clemente
British Journal of Nutrition, 2009, Volume 101, Number 07, Page 967
Ami S Bhatt, Hediye Erdjument-Bromage, Paul Tempst, Charles S Craik, and Mark M Moasser
Oncogene, 2005, Volume 24, Number 34, Page 5333

Comments (0)

Please log in or register to comment.